blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2046800

EP2046800 - 6-CARBOXY-NORMORPHINAN DERIVATIVES, SYNTHESIS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.09.2011
Database last updated on 24.04.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Wyeth LLC
Five Giralda Farms
Madison, NJ 07940 / US
[2010/16]
Former [2009/16]For all designated states
Wyeth
5 Giralda Farms
Madison, NJ 07940 / US
Inventor(s)01 / SHAH, Syed, M.
1 Ora Court
East Hanover, NJ 07936 / US
02 / ALI, Kadum, A.
32 Massachusetts Avenue
Congers, NY 10920 / US
03 / KONG, FangMing
620 Birch Avenue
River Vale, NJ 07675 / US
04 / ZHU, Tianmin
5 Wiltman Place
Monroe, NY 10950 / US
05 / GOMBAR, Charles, T.
1652 Bow Tree Drive
West Chester, PA 19380 / US
 [2009/16]
Representative(s)Rudge, Andrew John, et al
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
[N/P]
Former [2010/16]Rudge, Andrew John, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich CT13 9NJ / GB
Former [2009/16]Talbott, Dawn Jacqueline
Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead
Berkshire SL6 0PH / GB
Application number, filing date07811067.303.08.2007
[2009/16]
WO2007US17365
Priority number, dateUS20060835687P04.08.2006         Original published format: US 835687 P
[2009/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008016704
Date:07.02.2008
Language:EN
[2008/06]
Type: A1 Application with search report 
No.:EP2046800
Date:15.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 07.02.2008 takes the place of the publication of the European patent application.
[2009/16]
Type: B1 Patent specification 
No.:EP2046800
Date:27.10.2010
Language:EN
[2010/43]
Search report(s)International search report - published on:EP07.02.2008
ClassificationIPC:C07D491/04, A61K31/4355, A61P25/36
[2009/16]
CPC:
C07D491/04 (EP,US); A61P1/00 (EP); A61P1/08 (EP);
A61P25/04 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/30 (EP); A61P25/36 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61P9/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/16]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:6-CARBOXY-NORMORPHINAN-DERIVATE, IHRE SYNTHESE UND VERWENDUNG[2009/16]
English:6-CARBOXY-NORMORPHINAN DERIVATIVES, SYNTHESIS AND USES THEREOF[2009/16]
French:DÉRIVÉS DE 6-CARBOXY-NORMORPHINANE, SYNTHÈSE ET APPLICATIONS[2009/16]
Entry into regional phase04.02.2009National basic fee paid 
04.02.2009Designation fee(s) paid 
04.02.2009Examination fee paid 
Examination procedure04.02.2009Examination requested  [2009/16]
06.07.2009Despatch of a communication from the examining division (Time limit: M04)
11.11.2009Reply to a communication from the examining division
01.03.2010Communication of intention to grant the patent
11.06.2010Fee for grant paid
11.06.2010Fee for publishing/printing paid
Opposition(s)28.07.2011No opposition filed within time limit [2011/40]
Fees paidRenewal fee
07.08.2009Renewal fee patent year 03
31.08.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.10.2010
BE27.10.2010
CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
HU27.10.2010
IT27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
NL27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
TR27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
[2013/45]
Former [2013/44]AT27.10.2010
BE27.10.2010
CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
IT27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
NL27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
TR27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2013/26]AT27.10.2010
BE27.10.2010
CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
IT27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
NL27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2012/05]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
IT27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
NL27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2012/03]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
IT27.10.2010
LT27.10.2010
LV27.10.2010
NL27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2011/38]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
NL27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2011/35]AT27.10.2010
BE27.10.2010
CZ27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
NL27.10.2010
SE27.10.2010
SI27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2011/34]AT27.10.2010
BE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
NL27.10.2010
SE27.10.2010
SI27.10.2010
BG27.01.2011
GR28.01.2011
ES07.02.2011
IS27.02.2011
PT28.02.2011
Former [2011/29]AT27.10.2010
BE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
NL27.10.2010
SE27.10.2010
SI27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
Cited inInternational search[A]US4176186  (GOLDBERG LEON I [US], et al) [A] 1-35 * claims 1,4 *;
 [A]EP0663401  (TORAY INDUSTRIES [JP]) [A] 1-35 * Compounds 241-242 on pages 249-250;; claim 1 *;
 [A]WO2004043964  (MALLINCKRODT INC [US], et al) [A] 1-35 * claim 1 *;
 [A]  - YUAN CHUN-SU, "Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.", JOURNAL OF SUPPORTIVE ONCOLOGY, BIOLINK COMMUNICATIONS,, US, (200403), vol. 2, no. 2, ISSN 1544-6794, pages 111 - 117, XP002390438 [A] 1-35 * page 112; figure 1 *
 [A]  - FLEISCHHACKER W ET AL, "14-Methyl-Derivate des Morphins mit 5-,6- oder 7gliedrigem Ring C", MONATSHEFTE FUR CHEMIE, SPRINGER VERLAG. WIEN, AT, (1977), vol. 108, ISSN 0026-9247, pages 1441 - 1454, XP009091952 [A] 1-35 * page 142; example 2k *

DOI:   http://dx.doi.org/10.1007/BF01046459
 [A]  - GOERLITZER ET AL, "Darstellung und Charakterisierung von Bromierungsprodukten des Oxycodons", PHARMAZIE, DIE, GOVI VERLAG, ESCHBORN, DE, (1992), vol. 47, no. 12, ISSN 0031-7144, pages 893 - 897, XP001536594 [A] 1-35 * page 894, column 1 *
 [A]  - BOES ET AL, "A short and efficient synthesis of C-nor-dihydrocodeinone - the antipode of Goto's sinomenilone", HETEROCYCLES, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (1983), vol. 20, no. 6, ISSN 0385-5414, pages 1077 - 1081, XP009091976 [A] 1-35 * page 1077; examples 1,2 *
 [A]  - KRATZEL ET AL, "Synthesis of 5a,11b-propanonaphtho[1,2-e][1,2]oxazepines as potential opioid analgesics", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1, (1994), no. 11, pages 1541 - 1543, XP009092067 [A] 1-35 * examples 2a,2b *

DOI:   http://dx.doi.org/10.1039/p19940001541
 [A]  - KRATZEL ET AL, "An efficient synthesis of 14-halogenomethyl-substituted C-normorphinans", HETEROCYCLES, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (1987), vol. 26, no. 10, ISSN 0385-5414, pages 2703 - 2710, XP009092043 [A] 1-35 * page 2703; examples 4,7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.